By EconMatters
Valeant Pharmaceuticals – need a ‘fix it” third party to come in stop the bleeding. Moreover, the current management team is stuck in the deer in headlights mode, and needs to start taking proactive steps to resolve the overhangs that our weighing down investor confidence on the street.
© EconMatters All Rights Reserved | Facebook | Twitter | YouTube | Email Digest | Kindle
Запись Valeant Pharmaceuticals – The Perils of the Debt Acquisition Model (Video) впервые появилась crude-oil.top.